Home Drug Codes J Codes J0713 · CEFTAZIDIME
Updated July 1st, 2026

CEFTAZIDIME J Code: J0713

Injection, ceftazidime, per 500 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J0713, effective October 1, 2026: $1.549 per HCPCS billing unit, up 7.3% from $1.443. From CMS's final file.

?
Medicare Payment Limit ?
$1.443
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
15
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, ceftazidime, per 500 mg
HCPCS Added Date January 1, 1996
Manufacturer Multiple Manufacturers
Route of Administration Intramuscular, Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose, Multi-Dose
Dosage Form Injection, Powder, For Solution

About CEFTAZIDIME

Ceftazidime is a medication aligned to the HCPCS J Code: J0713 for billing, pricing, and reimbursement purposes in the United States. Classified under Antibiotic, it is administered via the intramuscular or intravenous routes and manufactured by multiple companies.

According to CMS Drug Use Information: Ceftazidime is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 15 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00409-5082-16 Tazicef Hospira, Inc. 50 Tazicef Intramuscular Injection 1 G/1 … Login for More
00409-5092-16 Tazicef Pfizer Inc 50 Tazicef Intravenous So lution Reconstit… Login for More
25021-0127-20 Ceftazidime Sagent Pharmaceuticals 50 Ceftazidime Intramuscu lar Injection 1 … Login for More
25021-0129-99 Ceftazidime Sagent Pharmaceuticals 72 6000 MG / 30 ML
44567-0235-25 Ceftazidime WG Critical Care, LLC 50 Ceftazidime Intramuscu lar Injection 1 … Login for More
•••••-••••-•• Log in to view CEFTAZIDIME
CEFTAZIDIME
CEFTAZIDIME
Login to view 10 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

CEFTAZIDIME Pricing & Reimbursement

J0713 Private Payer Reimbursement
$1.41 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

CEFTAZIDIME CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
96372 Login for More Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular Login for More
Not on the CMS JW / JZ list

CMS does not include Ceftazidime (J0713) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0713. Wastage billing guide →

CEFTAZIDIME Medically Unlikely Edits (MUE)

The most billing units of J0713 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 500 mg.

Practitioner Office & Hospital Outpatient
12 units / day
= 6,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

CEFTAZIDIME Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Bacterial Septicemia Bone and Joint Infections Central Nervous System Infections Gynecologic Infections Intra-abdominal Infections Lower Respiratory Tract Infections Skin and Skin-Structure Infections Urinary Tract Infections Urinary Tract Infections, complicated Urinary Tract Infections, uncomplicated
Drug Class
Cephalosporin Antibacterial [EPC]Cephalosporins [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Ceftazidime billing and coding guide?
We have not yet identified a manufacturer source of Ceftazidime billing and coding information.
Are there any available Ceftazidime patient assistance programs?
Our team did not identify a source for Ceftazidime patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Ceftazidime prescribing information?
Our team is still working to identify a prescribing information source for CEFTAZIDIME
Where can I find Ceftazidime side effect information?
Our team has not yet identified a source of side effects information for CEFTAZIDIME. Please check back in a few weeks.
Does billing CEFTAZIDIME require JZ/JW wastage modifiers?
CMS does not include CEFTAZIDIME (J0713) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0713. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.